These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 27230637)

  • 1. Epigenetic Changes in Diabetes and Cardiovascular Risk.
    Keating ST; Plutzky J; El-Osta A
    Circ Res; 2016 May; 118(11):1706-22. PubMed ID: 27230637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin Modifications Associated With Diabetes and Obesity.
    Schones DE; Leung A; Natarajan R
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1557-61. PubMed ID: 26044585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Contribution to the Development and Progression of Vascular Diabetic Complications.
    Rodriguez H; El-Osta A
    Antioxid Redox Signal; 2018 Oct; 29(11):1074-1091. PubMed ID: 29304555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications.
    Togliatto G; Dentelli P; Brizzi MF
    J Diabetes Res; 2015; 2015():373708. PubMed ID: 26064979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of epigenetic mechanisms in the vascular complications of diabetes.
    Reddy MA; Natarajan R
    Subcell Biochem; 2013; 61():435-54. PubMed ID: 23150262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspective.
    Paneni F; Costantino S; Volpe M; Lüscher TF; Cosentino F
    Atherosclerosis; 2013 Oct; 230(2):191-7. PubMed ID: 24075743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-independent persistence of PAI-1 gene expression and H3K4 tri-methylation in type 1 diabetic mouse endothelium: implication in metabolic memory.
    Takizawa F; Mizutani S; Ogawa Y; Sawada N
    Biochem Biophys Res Commun; 2013 Mar; 433(1):66-72. PubMed ID: 23454124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of epigenetics in the pathology of diabetic complications.
    Villeneuve LM; Natarajan R
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F14-25. PubMed ID: 20462972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic changes in diabetes.
    Keating ST; El-Osta A
    Clin Genet; 2013 Jul; 84(1):1-10. PubMed ID: 23398084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic processing in cardiometabolic disease.
    Costantino S; Mohammed SA; Ambrosini S; Paneni F
    Atherosclerosis; 2019 Feb; 281():150-158. PubMed ID: 30290963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting chromatin remodeling to prevent cardiovascular disease in diabetes.
    Costantino S; Paneni F; Cosentino F
    Curr Pharm Biotechnol; 2015; 16(6):531-43. PubMed ID: 25860064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics: mechanisms and implications for diabetic complications.
    Cooper ME; El-Osta A
    Circ Res; 2010 Dec; 107(12):1403-13. PubMed ID: 21148447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-methyladenine RNA methylation epigenetic modification and diabetic microvascular complications.
    Wang Y; Zou J; Zhou H
    Front Endocrinol (Lausanne); 2024; 15():1462146. PubMed ID: 39296713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes-induced epigenetic signature in vascular cells.
    Mitić T; Emanueli C
    Endocr Metab Immune Disord Drug Targets; 2012 Jun; 12(2):107-17. PubMed ID: 22236027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients.
    Sun D; Man W; Zhang L
    Curr Drug Targets; 2017; 18(15):1792-1799. PubMed ID: 27425648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Mechanisms in Diabetic Vascular Complications and Metabolic Memory: The 2020 Edwin Bierman Award Lecture.
    Natarajan R
    Diabetes; 2021 Feb; 70(2):328-337. PubMed ID: 33472942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic mechanisms in diabetic complications and metabolic memory.
    Reddy MA; Zhang E; Natarajan R
    Diabetologia; 2015 Mar; 58(3):443-55. PubMed ID: 25481708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms.
    Xiao M; Tang Y; Wang S; Wang J; Wang J; Guo Y; Zhang J; Gu J
    Front Endocrinol (Lausanne); 2021; 12():598008. PubMed ID: 34349728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic memory associated epigenetic changes.
    Siebel AL; Fernandez AZ; El-Osta A
    Biochem Pharmacol; 2010 Dec; 80(12):1853-9. PubMed ID: 20599797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus.
    Paneni F; Costantino S; Battista R; Castello L; Capretti G; Chiandotto S; Scavone G; Villano A; Pitocco D; Lanza G; Volpe M; Lüscher TF; Cosentino F
    Circ Cardiovasc Genet; 2015 Feb; 8(1):150-8. PubMed ID: 25472959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.